1. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis
   Fatemeh Vafaee et al, 2017, Sci Rep CrossRef
2. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and promotes tumorigenesis in thyroid carcinoma
   Xiangqing Xiong et al, 2017, Biomedicine & Pharmacotherapy CrossRef
3. Molecular Crosstalking among Noncoding RNAs: A New Network Layer of Genome Regulation in Cancer
   Marco Ragusa et al, 2017, International Journal of Genomics CrossRef
4. Long non-coding RNA CASC7 inhibits the proliferation and migration of colon cancer cells via inhibiting microRNA-21
   Ziwen Zhang et al, 2017, Biomedicine & Pharmacotherapy CrossRef
5. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma
   Kefeng Wang et al, 2017, Mol Cancer CrossRef
6. Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma
   Yuanyuan Gan et al, 2017, Tumour Biol. CrossRef
7. LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer
   Haoyu Zhou et al, 2017, Cancer Gene Ther CrossRef
8. Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma
   Lu Jin et al, 2017 CrossRef
9. Up-regulated lncRNA-MSX2P1 promotes the growth of IL-22-stimulated keratinocytes by inhibiting miR-6731-5p and activating S100A7
   Meng Qiao et al, 2018, Experimental Cell Research CrossRef
10. Long non-coding RNAs: An essential emerging field in kidney pathogenesis.
    Hakimeh Moghaddas Sani et al, 2018, Biomed Pharmacother CrossRef
11. CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3
    Xiaoxin Jin et al, 2018, Cell Death Dis CrossRef
12. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma.
    Zhiqiong Wang et al, 2018, Acta Biochim Biophys Sin (Shanghai) CrossRef
13. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway
    Suxian Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
14. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis
    Liang Zhao et al, 2018, J Cell Physiol CrossRef
15. Epigenetics in renal cell cancer: mechanisms and clinical applications.
    Sophie C Joosten et al, 2018, Nat Rev Urol CrossRef
16. Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinoma
    Qianwei Xing et al, 2018 CrossRef
17. CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.
    Xin Yu et al, 2018, Cell Prolif CrossRef
18. Long non-coding RNA CASC2 in solid tumors: A meta-analysis
    Chaojie Liang et al, 2018, Clinica Chimica Acta CrossRef
19. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells
    Xiang Gao et al, 2018, J Cell Physiol CrossRef
20. Downregulation of lncRNA CASC2 promotes the postoperative local recurrence of early oral squamous cell carcinoma
    Yao Dong et al, 2018, Eur Arch Otorhinolaryngol CrossRef
21. HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling
    Yaqun Yu et al, 2018, J Cell Biochem CrossRef
22. Long non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell proliferation, migration and invasion through miR-93-5p/PDCD4 pathway
    Changyu Chen et al, 2018, Clinics and Research in Hepatology and Gastroenterology CrossRef
23. Long non-coding RNA CASC2 suppresses pulmonary artery smooth muscle cell proliferation and phenotypic switch in hypoxia-induced pulmonary hypertension
    Junsong Gong et al, 2019, Respir Res CrossRef
24. Noncoding RNAs and Its Implication as Biomarkers in Renal Cell Carcinoma: A Systematic Analysis
    Shiv Verma et al, 2019, ann urol oncol CrossRef
25. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma
    Yingxia Li et al, 2019, Life Sciences CrossRef
26. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review
    Heewa Shakib et al, 2019, Endocrine CrossRef
27. Long non‐coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance
    Noha S. Refai et al, 2019, J Gene Med CrossRef
28. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Jiang-Hui Zeng et al, 2019, J Transl Med CrossRef
29. Long non-coding RNA CASC2 in human cancer
    Giuseppe Palmieri et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
30. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
    Yiwei Liao et al, 2017, J Cell Biochem CrossRef
31. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.
    Yeqian Feng et al, 0 CrossRef
32. Click RNA for Rapid Capture and Identification of Intracellular MicroRNA Targets
    Pengjuan Zhang et al, 2019, Anal. Chem. CrossRef
33. Long noncoding RNAs in renal diseases
    Minghui Liu et al, 2019, ExRNA CrossRef
34. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications
    Ming Li et al, 2017, Oncotarget CrossRef
35. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway
    Zhijun Pei et al, 2017, Oncotarget CrossRef
36. LincRNA FEZF1-AS1 contributes to the proliferation of LAD cells by silencing p57 expression
    Shuai Jin et al, 2017, Oncotarget CrossRef
37. The role of long non-coding RNA CASC2 in the carcinogenesis process.
    Soudeh Ghafouri-Fard et al, 2020, Biomed Pharmacother CrossRef
38. Metformin inhibits HaCaT cell viability via the miR-21/PTEN/Akt signaling pathway
    Yue Deng et al, 2017, Mol Med Report CrossRef
39. Mechanism of long non-coding RNA MALAT1 in lipopolysaccharide-induced acute kidney injury is mediated by the miR-146a/NF-κB signaling pathway.
    Ying Ding et al, 2018, Int J Mol Med CrossRef
40. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma
    Lingyun Lu et al, 2017, Mol Med Report CrossRef
41. Long non‑coding RNA CASC2 ameliorates sepsis‑induced acute kidney injury by regulating the miR‑155 and NF‑κB pathway
    Min Wang et al, 2020, Int J Mol Med CrossRef
42. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer
    Zhuowei Xue et al, 2018, Mol Med Report CrossRef
43. lncRNA CASC2 downregulation participates in rheumatoid arthritis, and CASC2 overexpression promotes the apoptosis of fibroblast‑like synoviocytes by downregulating IL‑17
    Cheng Liu et al, 2020, Mol Med Report CrossRef
44. Silencing of the long non‑coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial‑mesenchymal transition
    Wenjie Xie et al, 2019, Oncol Lett CrossRef
45. The Role of CASC2 and miR-21 Interplay in Glioma Malignancy and Patient Outcome
    Daina Skiriute et al, 2020, IJMS CrossRef
46. Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma
    Guiyun Cheng et al, 2020, Front. Oncol. CrossRef
47. Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease
    Cassandra Millet-Boureima et al, 2021, IJMS CrossRef
48. Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients’ survival by downregulating miR-21
    Jianchao Gao et al, 2021, BMC Cancer CrossRef
49. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Fei Huang et al, 0 CrossRef
50. The Long Noncoding RNA ANRIL Promotes Cell Apoptosis in Lipopolysaccharide-Induced Acute Kidney Injury Mediated by the TLR4/Nuclear Factor-Kappa B Pathway
    Ye Zhu et al, 2020, Kidney Blood Press Res CrossRef
51. Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1
    Yankun Zhang et al, 2019, oncol res CrossRef
52. Knockdown of Long Noncoding RNA CAT104 Inhibits the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells by Regulating MicroRNA-381
    Bo Xia et al, 2018, oncol res CrossRef
53. Upregulation of lncRNA CASC2 Suppresses Cell Proliferation and Metastasis of Breast Cancer via Inactivation of the TGF-β Signaling Pathway
    Yang Zhang et al, 2019, oncol res CrossRef
54. null
    Eman A. Toraih et al, 2022 CrossRef
55. Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance
    Jiajia Li et al, 2022, Cancers CrossRef
56. Long non-coding RNAs: a valuable biomarker for metabolic syndrome
    Mohammad Rashidmayvan et al, 2022, Mol Genet Genomics CrossRef
57. ETV5-mediated upregulation of lncRNA CTBP1-DT as a ceRNA facilitates HGSOC progression by regulating miR-188-5p/MAP3K3 axis
    Ping Liu et al, 2021, Cell Death Dis CrossRef
58. Altered expression of serum lncRNA CASC2 and miRNA-21-5p in COVID-19 patients
    Shymaa E. Ayoub et al, 2024, Hum Genomics CrossRef
59. LncRNA CASC2 Alleviates Renal Interstitial Inflammation and Fibrosis through MEF2C Downregulation-Induced Hinderance of M1 Macrophage Polarization
    Jinping Hu et al, 2023, Nephron CrossRef